These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20466268)

  • 21. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
    Walsh TJ
    Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infectious risk in pediatric organ transplant recipients: is it increased with the new immunosuppressive agents?
    Renoult E; Buteau C; Lamarre V; Turgeon N; Tapiero B
    Pediatr Transplant; 2005 Aug; 9(4):470-9. PubMed ID: 16048599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurological complications of transplantation].
    Martínez-Hernández E; Rosenfeld MR; Pruitt A; Dalmau J
    Neurologia; 2008; 23(6):373-86. PubMed ID: 18597192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological risk factors for infection after immunosuppressive and biologic therapies.
    Carbone J; del Pozo N; Gallego A; Sarmiento E
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):405-13. PubMed ID: 21504398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging of complications of hematopoietic stem cell transplantation.
    Jagannathan JP; Ramaiya N; Gill RR; Alyea EP; Ros P
    Radiol Clin North Am; 2008 Mar; 46(2):397-417, x. PubMed ID: 18619387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-transplant lymphoproliferative disorder.
    Loren AW; Tsai DE
    Clin Chest Med; 2005 Dec; 26(4):631-45, vii. PubMed ID: 16263402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection in organ transplant recipients.
    Hibberd PL; Snydman DR
    Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constant fear of rejection. Treating emergencies in transplant patients.
    Zavarella M; Benner R
    JEMS; 2007 Sep; 32(9):74-8, 80-8, quiz 90. PubMed ID: 17765097
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT.
    Ljungman P; Engelhard D; de la Cámara R; Einsele H; Locasciulli A; Martino R; Ribaud P; Ward K; Cordonnier C;
    Bone Marrow Transplant; 2005 Apr; 35(8):737-46. PubMed ID: 15750612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Supportive therapy in patients with autologous hemopoietic stem cell transplantation].
    Piatkowska-Jakubas B; Hawrylecka D; Wójcik M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():108-14. PubMed ID: 10494191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases.
    Ikehara S
    J Autoimmun; 2008 May; 30(3):108-15. PubMed ID: 18249091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious complications of solid organ transplantation.
    Poghosyan T; Ackerman SJ; Ravenel JG
    Semin Roentgenol; 2007 Jan; 42(1):11-22. PubMed ID: 17174171
    [No Abstract]   [Full Text] [Related]  

  • 35. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections.
    Len O; Garzoni C; Lumbreras C; Molina I; Meije Y; Pahissa A; Grossi P;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():10-8. PubMed ID: 24476053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing face of graft-versus-host disease.
    Schaffer JV
    Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
    Akpek G; Lee SM; Anders V; Vogelsang GB
    Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplantation osteoporosis.
    Stein E; Ebeling P; Shane E
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):937-63; viii. PubMed ID: 17983930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated.
    Yokoe D; Casper C; Dubberke E; Lee G; Muñoz P; Palmore T; Sepkowitz K; Young JA; Donnelly JP; ; ; ; ; ; ; ; ;
    Bone Marrow Transplant; 2009 Oct; 44(8):495-507. PubMed ID: 19861984
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral health in cancer therapy.
    Rankin KV; Epstein J; Huber MA; Peterson DE; Plemons JM; Redding SS; Sanfillippo NJ; Schubert MM; Sonis ST
    Tex Dent J; 2009 May; 126(5):389-97, 406-19, 422-37. PubMed ID: 19492587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.